PCR for fragile X syndrome is a DNA test that amplifies the FMR1 gene region to detect and size CGG trinucleotide repeat expansions. It can identify normal, intermediate, premutation, and many full mutation alleles, though very large expansions and methylation status sometimes need supplementary Southern blot testing. Used on blood DNA, PCR aids diagnosis, carrier screening, and prenatal evaluation interpreted by genetic specialists.

The best test is molecular analysis of the FMR1 gene to measure CGG repeat number and methylation. Labs use PCR-based CGG sizing with reflex to Southern blot (or methylation-specific assays) to identify premutation and full-mutation alleles and assess methylation status. Testing is done on a blood sample and provides definitive diagnosis and carrier information.

To test for fragile X in pregnancy, start with carrier screening (blood test) for both parents to detect FMR1 CGG repeat expansions. If a parent is a carrier, prenatal diagnostic testing of the fetus is offered: chorionic villus sampling at about 10–13 weeks or amniocentesis at about 15–20 weeks, with molecular FMR1 analysis. Preimplantation genetic testing with IVF and genetic counselling are options.

PGT‑M (preimplantation genetic testing for monogenic disorders) for fragile X detects FMR1 CGG repeat expansions in embryos created by IVF. A single-cell genetic analysis (PCR/Southern blot/linkage) determines whether embryos carry a normal, premutation, or full‑mutation allele. Results guide embryo selection to reduce the chance of passing fragile X syndrome while preserving unaffected embryos for transfer; genetic counseling is recommended.

Fragile X testing costs vary: in the U.S. a diagnostic DNA test typically runs about $200–$1,200 (out‑of‑pocket can reach $1,500–$2,000); in the U.K. testing is generally provided free on the NHS, with private labs charging roughly £150–£500; in India prices commonly range INR 3,000–15,000 (~$40–200). Confirm exact fees and insurance coverage with your clinic or lab.

Turnaround varies by lab and method. Standard PCR-based fragile X testing on blood usually returns in about 1–3 weeks. If a Southern blot or full methylation analysis is required, it can take up to 3–4 weeks. Prenatal testing timelines vary but are typically similar; check with your clinic or the testing laboratory for exact expected timing.